What Is Deep Vein Thrombosis (DVT)? Causes, Symptoms, Risk Factors, Diagnosis, Treatment and Prevention
What Is Deep Vein Thrombosis?
Deep Vein Thrombosis is a medical condition in which a blood clot, known as a thrombus, forms in a deep vein.
It most commonly develops in the deep veins of the lower leg, thigh or pelvis, although it can also occur in other parts of the body, including the arms.
DVT is one form of venous thromboembolism (VTE).
The other major form is pulmonary embolism (PE). A pulmonary embolism can occur when part of a deep-vein clot breaks away, travels through the bloodstream and becomes lodged in an artery in the lungs. Therefore, recognizing and managing DVT promptly is important.
Some people with DVT experience noticeable leg pain and swelling.
However, DVT does not always cause obvious symptoms. As a result, people with known risk factors particularly after major surgery, serious illness or prolonged immobility may require preventive measures even when they feel well.
What Causes DVT?
Blood normally flows continuously through the veins while the body’s clotting system remains ready to stop excessive bleeding after an injury. DVT develops when conditions favor abnormal clot formation inside a deep vein.
Clinicians commonly understand DVT formation through Virchow’s triad, which describes three major processes that promote thrombosis:
1. Venous stasis: slow blood flow:
When blood moves too slowly through a vein, it becomes more likely to clot.
The calf muscles normally act like a natural pump. When you walk or move your legs, muscle contractions help push venous blood upward toward the heart.
However, this mechanism becomes less effective during prolonged immobility. Consequently, blood may remain relatively stagnant in the deep veins of the legs.
Situations associated with reduced mobility include:
- prolonged bed rest
- recovery after major surgery
- admission to an intensive care unit
- paralysis or limited mobility
- a limb immobilised in a cast
- prolonged sitting
- long-distance travel
2. Damage to the blood vessel wall:
Surgery, major injury, inflammation and certain medical procedures may damage or alter the inner lining of a vein. Such changes can activate the body’s clotting mechanisms and contribute to thrombus formation.
3. Increased tendency of the blood to clot:
Certain diseases, medications, inherited conditions and physiological states can make the blood more prone to clotting.
For example, cancer, pregnancy and some inherited thrombophilias may increase the risk.
Therefore, DVT usually results from an interaction between slower blood flow, vascular injury and increased blood coagulability, rather than from one single cause.
What Are the Symptoms?
Common symptoms include:
- swelling in the affected leg
- pain or tenderness
- aching or cramping
- increased warmth around the affected area
- red or discolored skin
DVT frequently affects one leg, although symptoms alone cannot reliably confirm or exclude the condition.
Can DVT occur without symptoms?
Yes. DVT may occur without obvious symptoms.
This is particularly important in hospitalised and postoperative patients because reduced mobility and illness may increase thrombosis risk even when a patient does not report typical leg symptoms.
For this reason, healthcare professionals assess a patient’s overall VTE risk instead of relying only on symptoms.
When Does DVT Become an Emergency?
The most serious immediate complication of DVT is pulmonary embolism (PE).
A pulmonary embolism may develop when part of a clot separates and travels through the bloodstream to the lungs, where it can obstruct pulmonary blood flow.
Seek urgent medical attention if symptoms suggestive of DVT are accompanied by signs such as:
- sudden shortness of breath
- chest pain, particularly pain associated with breathing
- coughing up blood
- fainting or severe light-headedness
- unexplained rapid heartbeat
A pulmonary embolism can be life-threatening and requires urgent medical assessment.
What Are the Risk Factors ?
Anyone can develop DVT. However, some people have a substantially higher risk than others.
Furthermore, risk often increases when several factors occur together.
Major risk factors include:
1. Surgery:
Major operations can increase DVT risk because surgery may injure tissues and blood vessels while postoperative recovery can significantly reduce mobility.
Certain major procedures, particularly those followed by prolonged immobility, require structured VTE risk assessment and prophylaxis.
2. Hospitalization and prolonged immobility:
Patients confined to a hospital bed may not activate their calf muscles as frequently as people who walk normally.
Consequently, venous blood flow may slow.
3. Major injury or trauma:
Trauma can damage blood vessels and may also require immobilization, creating multiple factors that favor clot formation.
4. Increasing age:
DVT can occur at any age. Nevertheless, risk generally rises with increasing age.
5. Previous DVT or pulmonary embolism:
A person who has previously experienced VTE may have an increased risk of another event.
6. Cancer:
Some cancers and cancer treatments increase the body’s tendency to form blood clots.
7. Pregnancy and the postpartum period:
Pregnancy produces physiological changes in circulation and coagulation that can increase VTE risk.
8. Oestrogen-containing medicines:
Certain hormonal therapies, including some contraceptives and hormone replacement treatments, may increase clotting risk in susceptible individuals.
10. Obesity:
Obesity can contribute to VTE risk, particularly when combined with immobility, surgery or other risk factors.
11. Inherited or acquired clotting disorders:
Some people have conditions that make their blood more likely to clot than normal.
12. Long-distance travel:
Sitting in one position for prolonged periods can reduce leg movement and venous circulation. Risk is particularly relevant in people who already have additional VTE risk factors.
Healthcare providers therefore consider the combined clinical risk profile when deciding whether a patient requires DVT prophylaxis.
How Is DVT Diagnosed?
Symptoms such as leg swelling and pain can occur for many reasons. Therefore, healthcare professionals cannot diagnose DVT reliably from symptoms alone.
Diagnosis typically combines clinical assessment, medical history, risk evaluation, blood testing and imaging.
1. Medical history and physical examination
A clinician may ask about:
- current symptoms
- recent surgery
- hospitalisation
- prolonged immobility
- previous DVT or PE
- cancer
- medications
- recent injuries or infections
- other medical conditions
The affected limb may also be examined for swelling, tenderness, warmth and skin changes.
2. D-dimer blood test
D-dimer is a substance associated with the breakdown of blood clots.
A D-dimer test can form part of a diagnostic pathway, particularly when the clinical probability of DVT is relatively low. However, an elevated D-dimer does not automatically mean that a patient has DVT, because levels can rise for several other reasons. Therefore, clinicians interpret the result alongside the patient’s clinical probability and other findings.
3. Compression ultrasonography
Compression ultrasound is a key imaging test used to investigate suspected DVT.
Ultrasound uses sound waves to examine the deep veins and evaluate whether they compress normally. A vein containing a thrombus may not compress as expected.
4. Additional imaging
When ultrasound does not provide a clear answer or when the suspected clot is located in an area that is difficult to evaluate, additional imaging may sometimes be necessary.
For example, magnetic resonance venography may be considered in selected circumstances.
How Is DVT Treated?
The goals of treatment are to:
- prevent the existing clot from becoming larger,
- reduce the risk of pulmonary embolism,
- prevent additional blood clots, and
- reduce longer-term complications.
Treatment depends on the location and extent of the clot, the patient’s symptoms, bleeding risk, medical history and other clinical factors.
Anticoagulant medicines:
Anticoagulants are a central treatment for many patients with DVT.
Often called “blood thinners,” anticoagulants do not simply dissolve a clot immediately. Instead, they reduce the blood’s ability to form or extend clots, allowing the body’s natural processes to gradually deal with the existing thrombus.
Options can include heparin, warfarin and direct oral anticoagulants (DOACs), depending on the individual patient.
The duration of anticoagulation varies. Some patients may need treatment for several months, while others may require longer therapy depending on why the DVT occurred and their risk of recurrence.
Because anticoagulants can increase bleeding risk, patients should take them only as prescribed and remain under appropriate medical supervision.
Thrombolytic therapy and procedures:
In selected severe cases, clinicians may consider therapies intended to break down or remove a clot more rapidly.
However, these approaches are not suitable for every patient because they can carry significant bleeding and procedural risks. A specialist therefore determines whether their potential benefit outweighs the risks.
Can DVT Be Prevented?
Many DVT cases are associated with identifiable risk factors. Therefore, prevention plays an important role, especially in hospitals and during recovery after surgery.
DVT prevention may involve a combination of mobility, appropriate hydration, pharmacological prophylaxis and mechanical prophylaxis, depending on an individual’s clinical condition.
1. Encourage movement when medically appropriate
Regular movement activates the calf-muscle pump and promotes venous blood flow.
After surgery or hospitalisation, healthcare teams may encourage patients to begin moving as soon as it is clinically safe.
Even simple ankle and foot movements may be useful when a patient cannot yet walk, although patients should follow the instructions of their clinical team.
2. Avoid unnecessary prolonged immobility
During long periods of sitting, changing position and moving the legs regularly can help maintain circulation.
People undertaking long-distance journeys should discuss additional preventive measures with a healthcare professional if they already have significant VTE risk factors.
3. Pharmacological DVT prophylaxis
Patients at increased risk may receive preventive anticoagulant medication.
However, anticoagulants can increase bleeding risk. Therefore, clinicians balance the patient’s risk of thrombosis against their risk of bleeding before prescribing pharmacological prophylaxis.
4. Mechanical DVT prophylaxis
For appropriately selected patients, healthcare professionals may use mechanical methods to support venous circulation.
One important approach is intermittent pneumatic compression (IPC).
Clinical guidelines recognize pneumatic compression devices as one of the mechanical options used for VTE prophylaxis in selected hospitalized and surgical patients.
What Is a DVT Pump?
A DVT pump, commonly referring to an intermittent pneumatic compression system, is a medical device used as part of mechanical prophylaxis.
The system generally consists of a pneumatic pump connected to compression sleeves or cuffs placed around the patient’s limbs.
During operation, the system periodically inflates and deflates the sleeves. This intermittent compression is intended to promote venous blood movement in patients whose normal muscle-pump activity may be reduced because of immobility.
Importantly, a DVT pump is generally used to help prevent venous thromboembolism in appropriately selected at-risk patients. It should not be interpreted as a device for independently treating a DVT that has already formed.
Dexup DVT Pump: Supporting Mechanical DVT Prophylaxis
In clinical settings where intermittent compression is selected as part of a patient’s VTE-prevention strategy, healthcare facilities require equipment designed specifically for controlled mechanical prophylaxis.
The Dexup DVT Pump is an intermittent compression device intended for DVT prophylaxis in clinical use. Dexup’s documentation identifies its intermittent compression equipment as being used for DVT prophylaxis.
By delivering intermittent pneumatic compression through compatible compression components, this category of device supports the mechanical approach to VTE prevention used for selected patients with reduced mobility.
Mechanical prophylaxis can be particularly relevant when a clinical team determines that a patient needs a non-pharmacological preventive approach. Guidelines from the American Society of Hematology, for example, include pneumatic compression devices among mechanical VTE-prophylaxis interventions. For major surgical patients receiving mechanical prophylaxis, ASH guidance suggests intermittent pneumatic compression devices over graduated compression stockings, although the recommendation is conditional and based on very-low-certainty evidence.
Similarly, NICE guidance includes intermittent pneumatic compression among mechanical VTE-prevention approaches for specific groups of hospitalised patients.
Therefore, the Dexup DVT Pump should be viewed as one component of a clinician-directed DVT-prevention protocol, rather than a replacement for individual risk assessment, early mobilization or anticoagulant prophylaxis when medication is clinically indicated.
The decision to use intermittent pneumatic compression and how long to use it should be made according to the patient’s condition, institutional protocols, applicable device instructions and the treating healthcare professional’s assessment.
DVT Prevention After Surgery
Surgery is one of the most important clinical situations in which healthcare professionals actively assess DVT risk.
A postoperative prevention plan may include:
- early mobilisation when medically safe
- leg and ankle movement
- appropriate fluid management
- anticoagulant prophylaxis when indicated
- intermittent pneumatic compression when indicated
- ongoing reassessment of thrombosis and bleeding risks
Importantly, DVT prevention is not the same for every surgical patient.
The correct strategy depends on factors such as the type of operation, age, mobility, previous VTE, bleeding risk, cancer status and other medical conditions.
Frequently Asked Questions
DVT is a blood clot that develops inside a deep vein, most commonly in the leg. The condition requires medical attention because part of the clot can potentially travel to the lungs and cause a pulmonary embolism.
DVT most commonly develops in the deep veins of the lower leg, thigh or pelvis. It can also occur in other areas, including the arm.
Possible signs include one-sided leg swelling, pain or tenderness, warmth, aching or cramping, and red or discoloured skin. However, some DVTs produce few or no noticeable symptoms.
Yes. The main immediate concern is that part of the blood clot may break away and travel to the lungs, causing a potentially life-threatening pulmonary embolism.
Movement helps activate the calf-muscle pump and promotes venous circulation.
Therefore, appropriate mobilization is an important part of many DVT-prevention strategies.
However, walking alone cannot eliminate DVT risk, especially in high-risk patients
Doctors assess symptoms and risk factors and may use tests such as D-dimer testing and compression ultrasonography. Additional imaging may occasionally be required.
A DVT pump provides intermittent pneumatic compression as a form of mechanical VTE prophylaxis. It is primarily used in appropriately selected at-risk patients to help reduce venous stasis and support DVT prevention.
No. A DVT pump should not be presented as a device that cures or dissolves an established DVT.
Confirmed DVT requires medical evaluation and an appropriate treatment plan, commonly involving anticoagulant therapy.
Patients undergoing certain surgeries, people with substantially reduced mobility and some acutely or critically ill hospitalized patients may require VTE prophylaxis.
However, healthcare professionals should assess each person’s individual thrombosis and bleeding risks before selecting preventive measures.
Key Takeaway
Deep Vein Thrombosis occurs when a blood clot develops in a deep vein, most commonly in the leg.
Reduced blood flow, injury to a vein and an increased tendency of the blood to clot are the three major mechanisms that contribute to DVT formation.
Although swelling, pain, tenderness, warmth and skin discolouration can occur, DVT may sometimes develop without clear symptoms. Early recognition matters because a clot can potentially travel to the lungs and cause a pulmonary embolism.
Fortunately, DVT risk can often be reduced. Depending on the patient’s clinical situation, prevention may involve early mobilization, anticoagulant medication and mechanical prophylaxis such as intermittent pneumatic compression.
Devices such as the Dexup DVT Pump can support clinician-directed mechanical DVT prophylaxis in appropriately selected patients. However, every prevention strategy should follow individual risk assessment, applicable clinical guidelines, institutional protocols and the device’s approved instructions for use.
Medical Disclaimer: This article is intended for general educational and informational purposes only. It does not replace medical advice, diagnosis or treatment from a qualified healthcare professional. Anyone with symptoms suggestive of DVT or pulmonary embolism should seek prompt medical evaluation.
Sources:
